Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

427 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The first-in-class bispecific antibody IBI318 (LY3434172) targeting PD-1 and PD-L1 in patients with advanced tumors: a phase Ia/Ib study.
Ruan DY, Wei XL, Liu FR, Hu XC, Zhang J, Ji DM, Huang DZ, Zhao YQ, Pan HM, Liao WJ, Yang KY, Xu N, Lu XX, Chen YL, Zhang W, Zhou H, Zhao HY, Xu RH. Ruan DY, et al. Among authors: wei xl. J Hematol Oncol. 2024 Nov 29;17(1):118. doi: 10.1186/s13045-024-01644-4. J Hematol Oncol. 2024. PMID: 39614368 Free PMC article. Clinical Trial.
Inhibitor of apoptosis proteins (IAP) inhibitor APG-1387 monotherapy or in combination with programmed cell death 1 (PD-1) inhibitor toripalimab in patients with advanced solid tumors: results from two phase I trials.
Liu FR, Wei XL, Feng WN, Zhao HY, Zhang Y, Wang ZQ, Zhang DS, Wang FH, Yang S, Pan W, Tian X, Men L, Wang H, Liang E, Wang C, Yang D, Zhai Y, Qiu MZ, Xu RH. Liu FR, et al. Among authors: wei xl. ESMO Open. 2024 Aug;9(8):103651. doi: 10.1016/j.esmoop.2024.103651. Epub 2024 Jul 25. ESMO Open. 2024. PMID: 39059062 Free PMC article. Clinical Trial.
427 results